SCHEMBL8157366

SCHEMBL8157366

CCOC(=O)CCCOc1ccccc1NC(=O)c1ccc(OCc2ccc(CC(C)C)cc2)c(C)c1C

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SRD5A2 P31213 1/20 0.67
▸ L3MBTL1 Q9Y468 3/20 0.46
▸ TSHR P16473 2/20 0.46
▸ MAPT P10636 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ TDP1 Q9NUW8 2/20 0.43
▸ POLB P06746 2/20 0.42
▸ BRD4 O60885 1/20 0.40
▸ PTPN1 P18031 1/20 0.40
▸ ADRA1D P25100 1/20 0.39
▸ ADRA1A P35348 1/20 0.39
▸ ADRA1B P35368 1/20 0.39
▸ MRGPRX1 Q96LB2 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ TRPV1 Q8NER1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8158311 0.91 SRD5A2 (0.80) SRD5A2L3MBTL1TSHRMAPTMAPK1
SCHEMBL9352477 0.85 SRD5A2 (0.50) SRD5A2MAPTHTTPOLBADRA1D
SCHEMBL9319481 0.84 SRD5A2 (0.80) SRD5A2L3MBTL1TSHRMAPTMAPK1
SCHEMBL8158368 0.82 SRD5A2 (0.65) SRD5A2L3MBTL1TSHRMAPTTDP1
SCHEMBL8162801 0.82 SRD5A2 (0.66) SRD5A2L3MBTL1TSHRMAPTMAPK1
SCHEMBL8156605 0.82 SRD5A2 (0.72) SRD5A2L3MBTL1MAPTTDP1POLB
SCHEMBL10422174 0.81 SRD5A2 (0.66) SRD5A2L3MBTL1TSHRMAPTTDP1
SCHEMBL8151661 0.81 SRD5A2 (0.63) SRD5A2L3MBTL1TSHRTDP1POLB
SCHEMBL8159789 0.80 SRD5A2 (1.00) SRD5A2L3MBTL1TSHRMAPTMAPK1
SCHEMBL8162470 0.80 SRD5A2 (0.67) SRD5A2L3MBTL1TSHRMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6046183-A SYNERGISTIC MIXTURE OF FINASTERIDE AND DOXAZOSIN MERCK & CO., INC. (US) 2000-04-04 — — US disclosed
US-5994362-A ADMINISTERING FINASTERIDE AND CASODEX MERCK & CO., INC. (US) 1999-11-30 — — US disclosed
WO-1992018132-A1 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA COMTAINING A 5 ALPHA-REDUCTASE INHIBITOR MERCK & CO., INC. (US) 1992-10-29 — — WO disclosed
WO-1992016233-A1 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF PROSTATIC CANCER CONTAINING A 5 ALPHA REDUCTASE INHIBITOR AND AN ANTIANDROGEN MERCK & CO., INC. (US) 1992-10-01 — — WO disclosed
EP-0291245-B1 BENZOYLAMINOPHENOXYBUTANOIC ACID DERIVATIVES ONO PHARMACEUTICAL CO., LTD. (JP) 1992-07-22 — — EP disclosed
US-4980372-A INHIBITORS OF 5-ALPHA-REDUCTASE; TREATING AND PREVENTING ALOPECIA, ACNES OR PROSTATIC HYPERTROPHY ONO PHARMACEUTICAL CO., LTD. (JP) 1990-12-25 — — US disclosed
EP-0291245-A2 Benzoylaminophenoxybutanoic acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 1988-11-17 — — EP disclosed
Send feedback